Evidently, the Tri-NAb played dual roles, as both NPαPDL1+α4-1BB and NPαPDL1+αNKG2A not only effectively promoted bridging between NK cells and tumor cells but also facilitated bridging and interactions between CD8+ T cells and tumor cells (Fig. 3h). The gene discussed is CD8A; the disease is neoplasm.